arrow
J

Jun Soo Kwon

Hanyang University Seoul Hospital
H指数:86
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unraveling Suicidal Ideation and Behaviors in a Global Cohort of Individuals at Clinical High-Risk for Psychosis: Multivariable Correlates and Subthreshold Psychotic Symptoms

揭示全球临床高风险精神分裂症个体中的自杀意念与行为:多变量相关因素和阈下精神病症状

2026-09-130
OAAI
Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder

强迫症中脑结构多维度改变的区域、功能及转录组学解码

2026-06-240
OAAI
Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis

局部化学构筑解释了与精神病临床高风险相关的广泛皮质变薄现象

2026-04-040
PRE
Brain structural abnormalities in treatment-resistant schizophrenia

治疗抵抗性精神分裂症的脑结构异常

2026-03-280
PRE
Altered frontal and occipital cortical microstructure in obsessive-compulsive disorder - a multisite mega-analysis

强迫症中额叶和枕叶皮层微结构的改变——一项多中心大样本分析

2026-03-150
OAAI
Executive function in Obsessive-Compulsive Disorder: A worldwide mega-analysis of task-based functional neuroimaging data of the ENIGMA-OCD consortium

强迫症中的执行功能:ENIGMA-OCD联盟的任务相关功能神经影像数据的全球大规模分析

2026-02-250
OAAI
Reactive astrocytes and network functional connectivity underlying cognitive symptoms in schizophrenia: a PET and fMRI study

精神分裂症认知症状的反应性星形胶质细胞和网络功能连接: PET和fMRI研究

2026-02-040
PRE
Structural brain abnormalities and aggression in schizophrenia: mega-analysis of data from 2095 patients and 2861 healthy controls via the ENIGMA consortium

精神分裂症中的结构脑异常与攻击行为:ENIGMA联盟对2095名患者和2861名健康对照者数据的元分析

2025-12-030
PRE
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them

精神分裂症复发: 临床研究标准和国际共识指南的系统评价

2025-11-011
PRE
Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study

精神分裂症临床高风险个体中的结构协方差网络拓扑:ENIGMA-CHR研究

2025-10-220
OA
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative

收集语言、语音声学和面部表情数据以预测精神分裂症及其他临床结果:AMP® SCZ倡议的策略

2025-10-150
OAAI
Premorbid functioning trajectories and the one-year course of cognitive performance in first-episode psychosis: a cluster analysis in PSYSCAN

发病前功能轨迹与首发精神分裂症认知表现的一年病程:一项PSYSCAN中的聚类分析

2025-09-010
OAAI
Stability of psychotic symptoms and safety in switching to aripiprazole once-monthly according to prior oral antipsychotic drugs

根据先前口服抗精神病药物,转换为阿立哌唑每月一次的稳定性和安全性(针对精神病症状)

2025-07-010
OA
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

加速药品合作计划®精神分裂症项目中的脑电图协议:测量指标的可靠性与稳定性

2025-06-060
OAAI